WHO – long-acting analogues not an essential medicine

A no deal Brexit could put lives at risk (updated)

IDDT slam the Government for "gambling with people's health". Includes latest government statement (20th March)
READ MORE
FreeStyle Libre

FreeStyle Libre online education programme launched. Criteria for availability from April 2019
READ MORE
The IDDT Lottery

A chance to win cash prizes and help fund FREE IDDT publications
READ MORE

News Releases

News Release Archive

Ramadan 2019 and fasting
Warning! Be careful about completing your driving licence application online!
If you shop on Amazon, here’s how you can help IDDT
Medical Device Awareness Card Now Available
DVLA Guidelines make it simpler for drivers with insulin treated diabetes
A no deal Brexit could put lives at risk (updated)
New Ulcer treatment could prevent 3,000 amputations a year
FreeStyle Libre latest News!!!
NHS Long-Term Plan
FreeStyle Libre
Pork insulin availability in the UK and Canada assured
NHS to provide life changing glucose monitors for Type 1 Diabetes patients
Leading experts slam current diabetes care in UK care homes – a Call to Action needed
Roche announces urgent recall on certain Accu-Chek Aviva and Performa test strips
Ramadan 2018 and fasting
DVLA changes regulations
Freestyle Libre available on the NHS!
Medtronic recall specific lots of infusion sets with all models of Medtronic insulin pumps
All Accu-Chek® Insight insulin pumps – risk of alarm failure
WHO – long-acting analogues not an essential medicine
Beef insulin discontinued
Soft Drinks Warning!
Driven to Despair
2017 – Getting back on track after Christmas
Childhood Obesity Strategy failing our children
Diabetes – What schools need to know
DVLA – Good News!
The National Diabetes Foot Care Audit (NDFA)
Diabetes care criticised
Motorists banned in error after faulty DVLA visual field test
Too many children and young people with diabetes not getting the care they need
National NHS Diabetes Prevention Programme
InDependent Diabetes Trust: Young diabetics ‘get worse care’
IDDT’s Position Statement – ‘pre-diabetes’
MBE Is Bolt From The Blue For Charity Chair
New insulin on the market – Insulin Degludec (Tresiba)
Diabetes community urges more support for older people
Warning to people with diabetes about dangerous herbal medicine
In 1 week, 60 hospital patients with diabetes develop preventable complications – National Audit
Passport for Diabetes in Care Settings
Launch of Passport for Diabetes in Care Settings
Type 2 Diabetes – Management & Medication
Cost of insulin analogues
Actos And The Risk Of Bladder Cancer – New Safety Warnings
Actraphane – are patients really at the centre of care
Marketing of insulin – a missed opportunity
IDDT Launch Patient Hospital Passports
IDDT Launch Public Awareness Campaign
IDDT’s Position Statement on DTCA
In Sickness and in Health
IDDT Triumphs in Australia

WHO – long-acting analogues not an essential medicine

Health Action International today issued a press release commending the decision by the World Health Organization (WHO) to reject a proposal to include long-acting analogue insulin on the WHO Model List of Essential Medicines (EML).

A decision to include long-acting analogue insulin on the EML would have increased pressure on national governments to purchase these insulins, which are seven to nine times more expensive than human insulin, while providing limited added value to users. The result would have been fewer people being treated and more deaths.

To read the full press release, including comments from Health Action International’s Dr Margaret Ewen, co-lead of the Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS) Study, please click here.